Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS
- PMID: 33469841
- DOI: 10.1007/s13402-020-00580-y
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS
Abstract
Background: Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in humans. Hypoxia has been correlated with the aggressive form of glial tumors, poor prognosis, recurrence and resistance to various therapies. MicroRNAs (miRNAs) have emerged as critical mediators of hypoxic responses and have shown great potential for cancer diagnostics and therapeutics. Here, we focus on the regulatory and functional characterization of miR-196a, a hypoxia-inducible miRNA, in GBM.
Methods: Hypoxia/HIF regulation of miR-196a was assessed by RT-qPCR, promoter-luciferase and ChIP assays in GBM cell lines. miR-196a levels were analyzed in The Cancer Genome Atlas (TCGA)-GBM, Chinese Glioma Genome Atlas (CGGA) and Indian GBM patient cohorts. miR-target interactions were studied using RNA/protein quantification and 3'UTR luciferase assays. The effect of miR-196a overexpression/inhibition was assessed on cellular viability, migration and apoptosis under hypoxia and normoxia. Microarray-based gene expression profiling studies were performrd to study the effect of miR-196a on the GBM cellular transcriptome under hypoxia.
Results: We identified miR-196a as a hypoxia-inducible and hypoxia-inducible factor (HIF)-regulated miRNA that plays an oncogenic role in GBM. miR-196a was found to be significantly up-regulated in TCGA-GBM, CGGA glioma as well as Indian GBM patient cohorts. miR-196a overexpression was found to induce cellular proliferation, migration, spheroid formation and colony formation and to inhibit apoptosis, while miR-196a inhibition using anti-miR-196a yielded opposite results, suggesting an oncogenic role of miR-196a in GBM. We further unveiled NRAS, AJAP1, TAOK1 and COL24A1 as direct targets of miR-196a. We also report a complex competitive regulation of oncogenic NRAS by miR-196a, miR-146a and let-7 in GBM. Analysis of microarray-based gene expression data obtained by miR-196a inhibition under hypoxia revealed a role of miR-196a in HIF, calcium adhesion, Wnt and cell adhesion pathways. Interestingly, miR-196a was found to positively regulate the expression of various genes involved in the induction or stabilization of HIFs and in maintenance of hypoxic conditions, thereby suggesting the existence of an indirect miR-196a/HIF positive feedback loop under hypoxia.
Conclusions: Overall, our work identifies a novel association between hypoxia/HIF signalling and miR-196a in GBM and suggests its therapeutic significance.
Keywords: Glioblastoma; HIF-1; Hypoxia; NRAS; miR-196a.
Similar articles
-
Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.BMC Genomics. 2014 Aug 17;15(1):686. doi: 10.1186/1471-2164-15-686. BMC Genomics. 2014. PMID: 25129238 Free PMC article.
-
The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids.Tissue Cell. 2021 Dec;73:101617. doi: 10.1016/j.tice.2021.101617. Epub 2021 Aug 12. Tissue Cell. 2021. PMID: 34418770
-
MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.Neuro Oncol. 2014 May;16(5):652-61. doi: 10.1093/neuonc/not307. Epub 2014 Jan 23. Neuro Oncol. 2014. PMID: 24463357 Free PMC article.
-
Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.BMC Cancer. 2022 Jun 11;22(1):642. doi: 10.1186/s12885-022-09682-2. BMC Cancer. 2022. PMID: 35690717 Free PMC article. Review.
-
Unraveling the noncoding RNA landscape in glioblastoma: from pathogenesis to precision therapeutics.Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9475-9502. doi: 10.1007/s00210-024-03265-7. Epub 2024 Jul 15. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39007929 Review.
Cited by
-
Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications.Int J Mol Sci. 2023 Feb 23;24(5):4430. doi: 10.3390/ijms24054430. Int J Mol Sci. 2023. PMID: 36901857 Free PMC article. Review.
-
Effect of differential hypoxia-related gene expression on glioblastoma.J Int Med Res. 2021 May;49(5):3000605211013774. doi: 10.1177/03000605211013774. J Int Med Res. 2021. PMID: 34024193 Free PMC article.
-
Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia.Front Neurol. 2023 Nov 30;14:1256745. doi: 10.3389/fneur.2023.1256745. eCollection 2023. Front Neurol. 2023. PMID: 38107644 Free PMC article.
-
circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets, Insulin-like Growth Factor Binding Protein 2 (IGFBP2) and NRAS Proto-Oncogene, GTPase (NRAS) in Glioblastoma.Int J Mol Sci. 2022 Nov 8;23(22):13676. doi: 10.3390/ijms232213676. Int J Mol Sci. 2022. PMID: 36430152 Free PMC article.
-
Hypoxia-induced one-carbon metabolic reprogramming in glioma stem-like cells.Life Med. 2023 Nov 23;2(6):lnad048. doi: 10.1093/lifemedi/lnad048. eCollection 2023 Dec. Life Med. 2023. PMID: 39872059 Free PMC article.
References
-
- H. Wang, T. Xu, Y. Jiang, Y. Yan, R. Qin, J. Chen, MicroRNAs in human glioblastoma: From bench to beside. Front. Biosci.- Landmark 20, 105–118 (2015)
-
- J.M. Arbeit, J.M. Brown, K.S.C. Chao, J.D. Chapman, W.C. Eckelman, A.W. Fyles, A.J. Giaccia, R.P. Hill, C.J. Koch, M.C. Krishna, K.A. Krohn, J.S. Lewis, R.P. Mason, G. Melillo, A.R. Padhani, G. Powis, J.G. Rajendran, R. Reba, S.P. Robinson, G.L. Semenza, H.M. Swartz, P. Vaupel, D. Yang, J.L. Tatum, Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int. J. Radiat. Biol. 82, 699–757 (2006) - PubMed
-
- A.M. Jubb, F.M. Buffa, A.L. Harris, Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis. J. Cell. Mol. Med. 14, 18–29 (2010) - PubMed
-
- S. Seidel, B.K. Garvalov, V. Wirta, L. von Stechow, A. Schänzer, K. Meletis, M. Wolter, D. Sommerlad, A.T. Henze, M. Nistér, G. Reifenberger, J. Lundeberg, J. Frisén, T. Acker, A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α. Brain 133, 983–995 (2010) - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous